Story perspectives
Cardinal Health Reports Strong Q1, Raises EPS Guidance
10/30/2025
39 8
1 of 1
Story summary
- Cardinal Health, Inc. reported strong first-quarter fiscal 2026 results, with adjusted EPS of $2.55.
- Revenue reached $64 billion, up 22% year over year and beating expectations by 8.4%.
- The Pharmaceutical and Specialty Solutions segment posted a 23% revenue rise driven by brand and specialty drug sales.
- The company raised its fiscal 2026 EPS guidance to $9.65–$9.85, with stock rising 10% in pre-market trading.
